Skip to main content
Caplight Logo









Modality Dx

Modality Dx

Private
Hillsboro, OregonHealthcare & Life Scienceshttps://modalitydx.com/

Last Round

Series E

Jul 15, 2020

Total Funding Raised

$5M

Company Overview

Modality Dx is a biotechnology company that develops rapid diagnostic test technologies for risk assessment and diagnosis in maternal health, diabetes, and autoimmune disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Precision Medicine, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

point-of-care diagnosticsPOC testingbiomarker discoverymedical diagnosticsprecision medicinemolecular diagnosticsrapid testingAI-driven diagnosticsclinical diagnosticsdiagnostic hardwarebiotech servicesmedical devicedigital healthbiomarker development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Modality Dx Comparables

Compare Modality Dx with similar companies based on industry and business-model similarity.

Modality Dx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BIOSYNEX
78%
Epinex Diagnostics, Inc.
77%
EKF Diagnostics Holdings plc
74%

Modality Dx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series EJul 15, 2020
Series CMar 12, 2015

Key People

Founding team and executive leadership

John Mack

COO President Diabetomics, Inc.

Executive Team

Modality Dx Investors

Notable investors and investment history

Modality Dx investors
InvestorRounds
Rogue Venture PartnersVC Round
VenturEastSeries C
Dudley FoundationVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors increased 85% MoM, reaching 1.5K.

  • Jul 15, 2020

    Completed a Series E funding round.

Modality Dx Filings

Explore SEC and related filing metadata, where available.

Modality Dx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Modality Dx's valuation, stock price, and market status.

Is Modality Dx a public or private company?

Modality Dx is a private company.

What is the current stock price of Modality Dx?

Modality Dx is a private company with no public stock price. No recent secondary market data is available.

How much is Modality Dx worth (valuation)?

Valuation information for Modality Dx is not publicly available.

Can I buy Modality Dx stock?

Modality Dx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Modality Dx's last funding round?

Modality Dx's most recent funding round was Series E on July 15, 2020.

Who are the main investors in Modality Dx?

Key investors in Modality Dx include VenturEast.

Will Modality Dx IPO soon?

No public IPO plans have been announced for Modality Dx.

How can I track Modality Dx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Modality Dx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHillsboro, Oregon
Employee Range20
Year Founded2010
Last FundingJul 15, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?